Penserra Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,584
| Closed | -$178K | – | 1130 |
|
|
2025
Q1 | $178K | Sell |
11,584
-40,059
| -78% | -$616K | ﹤0.01% | 752 |
|
|
2024
Q4 | $1.14M | Buy |
51,643
+42,152
| +444% | +$928K | 0.02% | 375 |
|
|
2024
Q3 | $171K | Sell |
9,491
-151,859
| -94% | -$2.74M | ﹤0.01% | 726 |
|
|
2024
Q2 | $2.62M | Buy |
161,350
+7,620
| +5% | +$124K | 0.03% | 320 |
|
|
2024
Q1 | $2.17M | Buy |
+153,730
| New | +$2.17M | 0.03% | 340 |
|
|
2018
Q4 | – | Sell |
-11,316
| Closed | -$243K | – | 777 |
|
|
2018
Q3 | $243K | Buy |
11,316
+1,599
| +16% | +$34.3K | 0.01% | 393 |
|
|
2018
Q2 | $236K | Buy |
9,717
+673
| +7% | +$16.3K | 0.01% | 299 |
|
|
2018
Q1 | $154K | Buy |
9,044
+714
| +9% | +$12.2K | 0.01% | 271 |
|
|
2017
Q4 | $157K | Buy |
8,330
+1,309
| +19% | +$24.7K | 0.02% | 235 |
|
|
2017
Q3 | $129K | Buy |
+7,021
| New | +$129K | 0.03% | 238 |
|